How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

Ionis presents new long-term data supporting durable efficacy and disease control with DAWNZERA® (donidalorsen) at ACAAI 2026 Annual Meeting

calendar_today November 12, 2026 person Ionis Pharmaceuticals, Inc. News Releases domain ionis-pharmaceuticals

DAWNZERA showed sustained HAE attack rate reduction and long-term safety over two years 71% HAE attack rate reduction maintained after two years on DAWNZERA compared to baseline for patients switching from another long-term prophylactic therapy Treatment effect maintained regardless of dosing

open_in_new Read original post